ALICIA ENCINAS: Open Payments
NPI 1548859895 · CERRITOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,363 in 126 payments from 21 companies in 2025. Trend: 2023 $103 · 2024 $2,312 · 2025 $2,363
Food & beverage: $2,363
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $529 |
| Janssen Biotech, Inc. | 15 | $360 |
| Aimmune Therapeutics, Inc. | 21 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $216 |
| Ipsen Biopharmaceuticals, Inc | 7 | $200 |
| Madrigal Pharmaceuticals | 5 | $142 |
| Ardelyx, Inc. | 5 | $131 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $112 |
| GENZYME CORPORATION | 3 | $79 |
| Intercept Pharmaceuticals, Inc. | 4 | $74 |
Products named: TREMFYA, IQIRVO, VOWST, RINVOQ, ENTYVIO, LINZESS, REZDIFFRA, IBSRELA.
Industry payments across CA — which companies pay providers there.
